Methods and formulations for the improvement of recovery following bone-impacting injury or surgery. The formulations disclosed herein preferably include a blood component with a pharmaceutical agent. The blood component is preferably whole blood or platelet-rich plasma. The pharmaceutical agent may be a glucocorticoid hormone or other organic pharmaceutical agent. Particularly preferred pharmaceutical agents include dexamethasone, betamethasone, triamcinolone hexacetonide, melatonin, purmorpham...

The present invention is directed to a composition for treating bacterial skin infections & skin inflammation along with skin rejuvenation. More particularly the present invention relates to a pharmaceutical cream comprising a biopolymer a corticosteroid and an antibacterial active ingredient. It discloses a composition for treating bacterial skin infections & skin inflammation along with skin rejuvenation containing a) a biopolymer in the form of chitosan b) a combination of active pharmaceutic...

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medical industry and may be used in preparing medical agents stimulating wound and burn healing of various aetiologies and consisting of an absorbent material impregnated with medical agents. The absorbent material is a nonwoven perforated material, and is used as a medical agent presented by a gel mixture of boric acid, hydroxypropylmethyl cellulose, lidocaine hydrochloride and purified water in the following proportions, wt %: boric...

FIELD: medicine pharmaceutics.SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a drug preparation containing 97.0-59.5 wt % of naltrexone base 0.5-3.0 wt % of corticosteroid specified in triamcinolone betamethasone or dexamethasone 2.0-37.0 wt % of a nitrogen-containing polymer composition and 0.2-0.5 wt % of stearic acid or magnesium stearate. The nitrogen-containing polymer composition contains N-vinylpyrrolidone and 2-methyl-5-vinylpyridine copolymer or a salt of...

Disclosed herein is a storage stable ointment suitable for treating psoriasis comprising: (a) a vitamin D compound, particularly calcipotriene